- Home
- GGB vs BLCO Comparison
GGB vs BLCO Comparison
Compare GGB & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGB
- BLCO
- Stock Information
- Founded
- GGB 1901
- BLCO 1853
- Country
- GGB Brazil
- BLCO Canada
- Employees
- GGB N/A
- BLCO N/A
- Industry
- GGB Steel/Iron Ore
- BLCO Ophthalmic Goods
- Sector
- GGB Industrials
- BLCO Health Care
- Exchange
- GGB Nasdaq
- BLCO Nasdaq
- Market Cap
- GGB 5.7B
- BLCO 4.9B
- IPO Year
- GGB 1999
- BLCO 2022
- Fundamental
- Price
- GGB $2.85
- BLCO $13.90
- Analyst Decision
- GGB Strong Buy
- BLCO Hold
- Analyst Count
- GGB 1
- BLCO 13
- Target Price
- GGB $3.80
- BLCO $15.83
- AVG Volume (30 Days)
- GGB 14.8M
- BLCO 753.2K
- Earning Date
- GGB 07-30-2025
- BLCO 07-30-2025
- Dividend Yield
- GGB 3.61%
- BLCO N/A
- EPS Growth
- GGB N/A
- BLCO N/A
- EPS
- GGB 0.27
- BLCO N/A
- Revenue
- GGB $11,893,560,444.00
- BLCO $4,829,000,000.00
- Revenue This Year
- GGB $7.47
- BLCO $6.99
- Revenue Next Year
- GGB $6.01
- BLCO $5.46
- P/E Ratio
- GGB $10.08
- BLCO N/A
- Revenue Growth
- GGB 2.92
- BLCO 11.94
- 52 Week Low
- GGB $2.27
- BLCO $10.45
- 52 Week High
- GGB $3.62
- BLCO $21.69
- Technical
- Relative Strength Index (RSI)
- GGB 42.48
- BLCO 62.52
- Support Level
- GGB $2.89
- BLCO $13.59
- Resistance Level
- GGB $3.02
- BLCO $14.26
- Average True Range (ATR)
- GGB 0.08
- BLCO 0.45
- MACD
- GGB -0.02
- BLCO 0.02
- Stochastic Oscillator
- GGB 6.25
- BLCO 77.00
About GGB Gerdau S.A.
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment.
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.